BioPortfolio - autoimmune pharmaceuticals AI 401
BioPortfolio - ai-401 nih BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life ... AutoImmune's AI-401 is an oral or nasally delivered . ...
http://www.bioportfolio.com/search/autoimmune_pharmaceutical...
|
In The Clinic - AI-401
AutoImmune's AI-401 is an oral or nasally delivered formulation of recombinant ... The NIH is currently in the planning stages for a confirmatory trial. ...
http://www.autoimmuneinc.com/clinic/401.html...
|
AutoImmune, Inc. Reports 2007 First Quarter Financial Results ...
The NIH has started a multicenter Phase III trial on our product, AI-401, to determine if treatment can delay or prevent Type I diabetes, and Colloral LLC,
...
http://www.biospace.com/news_story.aspx?NewsEntityId=55881...
|
Terbutaline modulation of human allergic skin reactions.
Terbutaline/administration & dosage. Terbutaline/pharmacology* Substances Terbutaline Grant Support 5T AI 07031/AI/NIAID AI14332/AI/NIAID AI401/AI/NIAID
...
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&d...
|
To Our Shareholders: 2007
... when the NIH began enrolling patients in a multi-center Phase III clinical trial on whether treatment with our product, AI 401, can delay or prevent ...
http://www.autoimmuneinc.com/News/letters/2007.html...
|
BioPortfolio - AutoImmune Incorporated - Profile
A third product, AI 401, for the treatment of Type 1 diabetes, ... by Eli Lilly and Company ("Lilly") and the National Institutes of Health ("NIH"). ...
http://www.bioportfolio.com/biocorporate/413-AutoImmune+Inco...
|
Temporal coupling between neuronal activity and blood flow in rat ...
... and filtered by a CyberAmp 320 with an AI 401 × 10 smartprobe (both from Axon Instruments). ..... NIH | Department of Health and Human Services ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=22...
|
